Greta Sommerhauser
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial.
Journal: EClinicalMedicine
Published: September 12, 2024
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial.
Journal: ESMO open
Published: April 04, 2024
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
Journal: Oncology research and treatment
Published: January 22, 2024
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
Journal: Oncology research and treatment
Published: January 21, 2024
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023.
Journal: Oncology research and treatment
Published: January 21, 2024
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 04, 2023
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 04, 2023
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 16, 2023
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
Journal: International journal of cancer
Published: March 09, 2023
Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies.
Journal: Pediatric blood & cancer
Published: February 01, 2023
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).
Journal: ESMO open
Published: February 01, 2023
Educational pathways of childhood cancer survivors-a parental cohort.
Journal: Journal of cancer survivorship : research and practice
Published: August 14, 2022
Last Updated: 09/26/2026